We and others previously demonstrated GDF8 and ActA are the two major ligands which mediate the muscle minimization actions of the ActRIIA/B receptors in non-obese mice and NHPs 22,28,30 , and we have further shown that dual blockade of GDF8 and ActA led to much larger increases in muscle mass than blocking either ligand individually, and that dual blockade matched the muscle growth actions of broader ActRIIA/B blockade 28 , similar to effects seen when using a dominant-negative type II receptor or pro-domains of GDF8 and activins 22,26,27
Tirzepatide partially counteracts this adaptation through its metabolic effects, which is one reason it produces such dramatic weight loss results over time
Very easy to understand and incredibly helpful
Many people who werent comfortable with injections may now take a closer look, simply because a daily pill feels easier and more familiar
The incidence decreased over time as patients developed tolerance, with most nausea episodes occurring during dose escalation periods
What does the Fosgonimeton clinical history mean for Dihexa research